General

Living with COVID- the role of antivirals

In the UK, we now seem to be moving into a new phase of pandemic management, with the government aiming to” transition to managing COVID-19 like other respiratory illnesses”. In their recent March 2022 statement, the government attributes this evolution in approach to vaccines and treatments. In this short article, we overview the current role of antivirals and monoclonal antibodies and look ahead to future developments in our attempt to manage the day-to day risks of living with COVID-19.

5 Apr 2022

Join Our Free Webinar: Medical Affairs 3.0: A Discipline Comes of Age – Focus on evidence generation & dissemination for strategic impact

Join Triducive and PharmaMedic for an interactive webinar on Thursday 28th April at 8.00AM. Keynote speakers Dr Malcolm Barratt-Johnson and Tim Warren will be discussing the strategic role of medical affairs in Pharma and the potential role of Delphi based studies for strategic impact. Find out more.

29 Mar 2022

The value of a pharmaceutical physician as a Non-Executive Director

Non-Executive Directors play an integral role for any organisation, not least within the life science space where leadership often needs to draw on a broad range of strategic and tactical expertise to drive the business forward. In this short Q&A article, we interview PharmaMedic Managing Director Dr Malcolm Barratt-Johnson about the value that a pharmaceutical physician delivers in the role of NED.

22 Mar 2022

Breakfast Briefing Takeaways: Medical affairs in 2022: Business as usual, or a reshaped environment

We enjoyed our first virtual breakfast briefing of 2022, with a new lively panel discussion format. Our guest panelists, Dr Lucy Cook (PharmaMedic consultant and Director of Wiltshire Pharma), Mr Guy Francis (UK Marketing Director, Amarin UK) and Mr Andy Wise (Managing Pharma Consultant, Blue Pelican) joined Dr Malcolm Barratt-Johnson to discuss key themes set to shape medical affairs in 2022. Read on for a summary of key takeaways and to access our recording of the event.

1 Mar 2022

How JP Morgan Healthcare trends inform pharma ‘mood music’ for 2022

The JP Morgan Healthcare conference is the flagship global investment focused event and marked its 40th year in January 2022 with a virtual event. Typically, the hot topics from JP Morgan set the tone for the life science community for the rest of the year. In this short round up, we will summarise some of the key themes and ‘mood music’ emerging from the conference that have been reported by the industry press.

15 Feb 2022

Join our Virtual Breakfast Briefing: Medical Affairs in 2022: Business as usual, or a reshaped environment?

PharmaMedic is delighted to announce our next virtual breakfast briefing on Thursday 24th February 2022 at 8 am. For this virtual session, we invite you to join experts Dr Malcolm Barratt-Johnson, Mr Guy Francis, Dr Lucy Cook and Mr Andrew Wise for a lively panel discussion tackling the key industry and medical affairs trends we expect to emerge in 2022 and how we can best adapt to succeed. Learn more about the agenda and register here.

2 Feb 2022

Expecting the unexpected – managing the impact of lack of supplies and shortages on the UK pharmaceutical sector

The petrol shortages earlier this quarter disrupted the country and impacted supply and distribution channels across sectors. In this new article we discuss issues affecting our vital UK pharmaceutical supply chain and the ways in which organisations can build resilience.

18 Nov 2021

How do we shape our professional development as consultants?

A life working as a consultant in the pharmaceutical industry offers substantial benefits, including flexibility and varied work. While consultants may not experience the defined career pathway we follow as an employee, we can still steer our professional journeys through mentorship, training, and networking. Read more to learn how.

19 Oct 2021

Virtual Breakfast Briefing: Shaping the UK’s position in the international community- innovation and regulatory perspectives

PharmaMedic is delighted to announce our next virtual event on Thursday 28th October 2021 at 8 am. As the UK life sciences sector continues its journey outside the EU, it’s time to forge a new role in the international community. This briefing will highlight some of the critical considerations we face from both innovation and regulatory perspectives. Learn more about the agenda and register here.

6 Oct 2021

A new horizon for medical devices regulation in the UK

With the government, the MHRA has launched a new consultation to shape a new era of medical device regulation in the UK. The objective is to create a framework that improves patient and public safety, increases transparency in regulatory decision-making, and aligns with global best practices. In this article, we summarise the issues and the scope of the potential changes.

22 Sep 2021